ClinMeta
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ClinMeta - overview
Established
2012
Location
Shanghai, -, China
Primary Industry
Medical Devices & Equipment
About
Established in 2012 and based in Shanghai, China, ClinMeta operates as a biopharmaceutical company that mainly provides comprehensive solution for clinical mass spectrometry. It has R&D bases in Shanghai and Canada, and production bases in Guangzhou and Taizhou. In January 2019, the company closed strategic financing from new investor Shenzhen KCH Investment. The company mainly provides clinical laboratory medicine solutions.
Products include fatty acid detection kits, folic acid detection kits, amino acid and carnitine tandem mass spectrometry detection kits. The company also provides medical institutions with personalized medical services and system solutions based on clinical mass spectrometry, including clinical metabolomics and proteomics medical testing solutions, as well as basic research and development of related medical testing products. The company generates revenue by providing clinical laboratory medicine solutions.
Current Investors
DAAN Gene, Shanghai Tonggao Investment Management Co., LTD, Fuzhou Jiliang Medical Technology Co. LTD
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Diagnostic Equipment
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.